The clinical implications of leukemia evolution

Date:
30
Monday
October
2017
Lecture / Seminar
Time: 14:00-15:00
Title: Cancer Research Club
Location: Max and Lillian Candiotty Building
Lecturer: Dr. Liran Shlush
Organizer: Department of Immunology and Regenerative Biology
Contact: li.tzoref@weizmann.ac.il
Abstract: Acute myeloid leukemia (AML) is a devastating disease with less than 10% of elde ... Read more Acute myeloid leukemia (AML) is a devastating disease with less than 10% of elderly patients survive five years. While AML originates from stem cells which evolve over many years it presents acutely due to the expansion of more committed progenitors. Over the recent years we were able to identify the origins of AML relapse, and also to study AML years before it is diagnosed. We now can predict AML 6 years before diagnosis. Future studies will soon provide evidence whether early treatment will be beneficial.
Close abstract